POM
POMDOCTOR LtdPrice
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- X Aug 14 Short interest jumps 36.4% to 26.0K
- X Aug 31 Short interest falls 25.2% to 19.4K
- X Sep 30 Short interest jumps 42.1% to 26.0K
- R Oct 9 POMDOCTOR received a Nasdaq staff delisting determination on October…
- E Oct 22 Trading halt: Halt Resumed: POM — trading resumed after LUDP (Volatility…
- E Oct 22 Trading halt: Trading Halt: POM — LUDP (Volatility Trading Pause)
Signal stack
Where each data set points today.
- TrendUPTREND
23% above its 50-day average.
- SocialQUIET
Crowd 50° (neutral) this week from 3 mentions: 0 bullish, 0 bearish. No setup call. Excludes 1 subscriber-only day.
Who's buying
13F| Top holder | Shares | Value |
|---|---|---|
| CITADEL ADVISORS LLC | 21,273 | $30.8K |
| UBS Group AG | 3,463 | $5.0K |
| Arax Advisory Partners | 722 | $1.0K |
| Steward Partners Investment Advisory, LLC | 111 | $161.00 |
| RHUMBLINE ADVISERS | 41 | $60.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Oct 15, 2026| Oct 22, 2026 | Volatility Pause | Resumed |
| Oct 22, 2026 | Volatility Pause | Resumed |
| Oct 22, 2026 | Volatility Pause | Resumed |
| Oct 22, 2026 | Volatility Pause | Resumed |
| Oct 22, 2026 | Volatility Pause | Resumed |
SecBot reports
15 filings · 1 bullish · 1 bearish · 1 mixed · 12 neutral- NEUTRAL 6-KOct 19, 2026
POMDOCTOR is terminating its ADR program and converting to a direct listing of Class A ordinary…
Monitor the first day of direct ordinary share trading on October 21 for liquidity and price discovery. The share consolidation ratio (10:1) and ADS-to-ordinary conversion (10 ADSs → 3 shares)…
- BEARISH 6-KOct 9, 2026
POMDOCTOR received a Nasdaq staff delisting determination on October 6, 2026, because its ADS bid…
The hearing deadline is October 13, 2026 — a timely request stays the suspension. The outcome is binary: if the Panel denies the appeal, the stock faces immediate delisting and likely a significant…
- NEUTRAL 6-KSep 30, 2026
POMDOCTOR Ltd filed a 6-K with a press release providing a strategic update on its AI-enabled…
This filing provides no new financial data or guidance. Monitor upcoming quarterly results for evidence of revenue generation from RWD commercialization and AI system deployment. The strategic…
- NEUTRAL 6-KSep 24, 2026
POMDOCTOR issued a press release highlighting its differentiated 'Hardware + AI + Payment'…
This is a strategic positioning release with no hard data — monitor upcoming quarterly filings for evidence of wearable device adoption, payment integration revenue, and platform metrics (GMV…
All POM filing & press-release reports (15)
- 6-K reportOct 19, 2026
- 6-K reportOct 9, 2026
- 6-K reportSep 30, 2026
- 6-K reportSep 24, 2026
- 6-K reportSep 10, 2026
- 6-K reportAug 27, 2026
- 6-K reportAug 10, 2026
- 6-K reportAug 3, 2026
- 6-K reportJul 15, 2026
- 6-K reportJul 13, 2026
- 6-K reportJul 9, 2026
- 6-K reportJul 2, 2026
- 6-K reportMay 28, 2026
- 6-K reportApr 20, 2026
- 6-K reportApr 8, 2026